Octreotide reduces alcohol-induced hypotension and orthostatic symptoms in primary autonomic failure.
Symptomatic postural hypotension is a major problem in patients with primary idiopathic autonomic failure, and ingestion of small quantities of alcohol may worsen the degree of postural hypotension. The proposed mechanisms include mesenteric vasodilation and release of vasodilatory gut peptides. We measured systemic, mesenteric, other regional vascular and biochemical responses to alcohol ingestion before and after pre-treatment with the somatostatin analogue Octreotide (which inhibits the release of a wide range of gut peptides normally released in response to food ingestion) in six patients with primary autonomic failure. Octreotide effectively prevented alcohol-induced hypotension and vasodilatation of the mesenteric vascular bed, with improvement of signs and symptoms of hypotension post-alcohol. This suggests that the mechanism of alcohol-induced symptomatic hypotension in autonomic failure is at least partly mediated by release of vasodilatatory gut peptides with resultant mesenteric vasodilatation.
D000368:Aged; D000428:Alcohol Drinking / Q000009:adverse effects*; D001342:Autonomic Nervous System Diseases / Q000097:blood / Q000150:complications*; D001783:Blood Flow Velocity / Q000187:drug effects; D004837:Epinephrine / Q000097:blood; D005765:Gastrointestinal Agents / Q000627:therapeutic use*; D006801:Humans; D007022:Hypotension / Q000139:chemically induced* / Q000517:prevention & control; D007024:Hypotension, Orthostatic / Q000188:drug therapy*; D007328:Insulin / Q000097:blood; D017538:Mesenteric Artery, Superior; D008875:Middle Aged; D015282:Octreotide / Q000627:therapeutic use*; D014655:Vascular Resistance / Q000187:drug effects
D005765:Gastrointestinal Agents; D007328:Insulin; D015282:Octreotide; D004837:Epinephrine